微创血肿清除与侧脑室引流术治疗小脑出血

目的：观察不同软通道微创手术方式治疗小脑出血的临床疗效。方法：高血压脑出血25例分成软通道微创血肿清除组（n=14）和侧脑室引流组（n=11）。以治疗后28天SSS和死亡率作为判断疗效的标准,比较两组的疗效。2组患者在入院时和入院后7 d行（格拉斯哥昏迷量表,Glasgow coma scale,GCS）评分,入院时和入院后14d及28d行（斯勘的纳维亚卒中量表,Scandinavianstroke scale,SSS）评分。结果：治疗组手术后SSS评分14d（t=3.65 P〈0.01）及30d（t=4.01,P〈0.01）,治疗组明显优于对照组。两组总有效率比较有显著差异（P〈0.05）。结论：软通道微创血肿清除术疗效优于单纯侧脑室引流术,其作为治疗小脑出血的微创治疗技术总体上是安全、有效的,明显降低了患者死亡率,提高了患者生存质量。

Microsurgery Hematoma and Ventricle Drainage for Cerebellar Hemorrhage

Objective： To investigate the clinical efficacy of different soft minimally invasive surgical treatment on cerebellar hemorrhage. Methods： A total of 25 cases of hypertensive intracerebral hemorrhage were divided into soft minimally invasive evacuation of hematoma group （n=14） and ventricle drainage group （n=1 1）. According to SSS and mortality of 28 days after treatment, the efficacy of the two groups were compared. At the time of admission and 7 d after admission, the two groups of patients were scored by Glasgow Coma Scale（GCS） ; at the time of admission and 14 d and 28 d after admission, for scandinavian Stroke Scale（SSS）. Results： SSS scoring in the treatment group after surgery： the total effective rate of 14 days and 30d of the treatment group was significantly better than that of control group,with significantly differences （P 〈0.05）. Conclusion： The soft minimally invasive hematoma evacuation surgery is more effective than pure lateral ventricle drainage. Generally speaking, it is safe, effective and is a minimally invasive treatment technology for cerebellar hemorrhage, for it significantly reduces mortality of patients and improves the quality of life of patients.